Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data
The Journal of Applied Laboratory Medicine · 04.11.2026 · 11 (6) · 1536-1545
DOI: 10.1093/jalm/jfag102 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 10.07.2026. Verfasst von Anders Larsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Clinical Chemistry and Pharmacology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Carbamazepine, Drug Monitoring, Anticonvulsants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University Hospital Research Fund.
Abstract (Originalsprache)
Background
Carbamazepine is an antiepileptic and mood-stabilizing drug with complex pharmacokinetics and a narrow therapeutic index, making therapeutic drug monitoring (TDM) essential. The therapeutic reference range for carbamazepine at our laboratory is 20–40 µmol/L (4.7–9.4 mg/L). Long-term laboratory data may help identify population trends, seasonal or demographic variation, and the suitability of patient-derived medians as a quality-assurance tool.
Methods
This retrospective study analyzed 12 577 serum carbamazepine results obtained between May 2007 and December 2025 at Uppsala University Hospital. The total number of unique individuals providing the test results was 3147. Demographic variables (age, sex) and sampling dates were included. Yearly percentiles were used to evaluate long-term trends, and monthly variation was assessed for seasonal effects. Equivalence of analytical results was examined during the transition from the Architect ci8200 to the Cobas Pro c503 platform (February 2021).
Results
Annual test volume peaked in 2010 (n = 955) and declined to 160 by 2025. Despite reduced testing, carbamazepine concentrations increased steadily over time, with median values rising from 25.2 µmol/L (5.9 mg/L) in 2007 to 31.2 µmol/L (7.4 mg/L) in 2025. Seasonal analysis showed predictable drops in sampling during the Swedish summer vacation period but no meaningful variation in drug concentrations. The method transition in February 2021 showed strong agreement between platforms, with slightly higher values on the Cobas system (Cobas = 1.049 × Architect − 0.164; R2 = 0.946).
Conclusions
Carbamazepine concentrations in routine patient samples have gradually increased over 2 decades, independent of declining test frequency. Seasonal workload fluctuations did not affect observed levels. Patient-derived medians were stable and sensitive to method changes, supporting their role as complementary internal quality-control tools. Long-term TDM databases provide valuable insights for both clinical interpretation and laboratory quality assurance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Clinical Chemistry and Pharmacology, Uppsala University, Uppsala, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
- NOVA Medical School, New University of Lisbon, Lisbon, Portugal.
- Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
- Clinical Department of Pain and Rehabilitation, Region Östergötland, Linköping, Sweden.
ORCID-Profile: Anders Larsson
Förderung
- Uppsala University Hospital Research Fund
Zitieren
APA
Larsson, A., Eriksson, M. B., Bäckryd, E., Steinholtz, L., & Hamberg, A. K. (2026). Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data. The Journal of Applied Laboratory Medicine, 11(6), 1536-1545. https://doi.org/10.1093/jalm/jfag102
Vancouver
Larsson A, Eriksson MB, Bäckryd E, Steinholtz L, Hamberg AK. Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data. The Journal of Applied Laboratory Medicine. 2026;11(6):1536-1545. doi:10.1093/jalm/jfag102
BibTeX
@article{Larsson2026,
author = {Larsson, Anders and Eriksson, Mats B and Bäckryd, Emmanuel and Steinholtz, Linda and Hamberg, Anna-Karin},
title = {Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {6},
pages = {1536--1545},
doi = {10.1093/jalm/jfag102}
}
EUVIMED